October 25, 2016 6:11 AM ET


Company Overview of Synageva BioPharma Corp.

Company Overview

Synageva BioPharma Corp. operates as a biopharmaceutical company in the United States. It focuses on the discovery, development, and commercialization of therapeutic products for patients with rare diseases. The company’s lead program include sebelipase alfa, a recombinant form of human lysosomal acid lipase (LAL) under the Kanuma brand name for the treatment of LAL deficiency in infants, children, and adults. It also has various other research programs in various stages of preclinical development, including SBC-103, an enzyme replacement therapy in a Phase 1/2 study for lysosomal storage disease, known as mucopolysaccharidosis type IIIB; SBC-105, an enzyme replacement therapy in preclinical...

33 Hayden Avenue

Lexington, MA 02421

United States

Founded in 1996

282 Employees





Key Executives for Synageva BioPharma Corp.

Synageva BioPharma Corp. does not have any Key Executives recorded.

Synageva BioPharma Corp. Key Developments

Synageva BioPharma Corp.(NasdaqGM:GEVA) dropped from MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index

Synageva BioPharma Corp.(NasdaqGM:GEVA) dropped from MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index

Synageva BioPharma Corp.(NasdaqGM:GEVA) dropped from CRSP US Total Market Index

Synageva BioPharma Corp.(NasdaqGM:GEVA) dropped from CRSP US Total Market Index

Synageva Biopharma Corp. Announces Resignation of Directors

Alexion Pharmaceuticals Inc. announced acquisition of Synageva BioPharma Corp. In connection with the first merger and as contemplated by the merger agreement, Michael V. Greco, became the sole director of the company. In connection therewith, each of Felix J. Baker, Stephen R. Biggar, Stephen R. Davis, Thomas R. Malley, Sanj K. Patel, Barry D. Quart, Thomas J. Tisch and Peter Wirth tendered their respective resignations as directors from the board of directors of the company and from all committees of the Board on which such directors served, effective as of the effective time.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Synageva BioPharma Corp., please visit www.synageva.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.